A Proposal of a New Tool for the Assessment of Damage in Behçet Syndrome Uveitis: Cerrahpasa Ocular Damage Grading System.

Introduction/objective: There is currently no tool available to assess the severity of damage in uveitis due to Behçet's syndrome (BS). In this preliminary study, we developed a new grading system to evaluate ocular damage and assessed it in a prospective cohort.

Methods: A specialist in BS uveitis (YO) developed a grading system for ocular damage with five grades based on the extent of damage in the posterior segment.

Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis.

Experience with mycophenolate in uveitis due to Behçet syndrome (BS) is limited. Twelve patients with panuveitis or posterior uveitis who were started mycophenolate were included. Data on demographic characteristics, therapies, ocular attacks, and adverse events were extracted from patient charts.

Pediatric Uveitis in Turkey: The National Registry Report II.

Purpose: To report demographic and clinical profiles of children with uveitis in theTurkishpopulation.

Methods: The data of the pediatric uveitis cases in the nation wide uveitis database were analyzed.

Results: The study included 697 eyes of 442 patients with a meanage of 10.

Emergence of new manifestations during infliximab treatment in Behçet's syndrome.

Objectives: Infliximab (IFX) is increasingly being used for the treatment of severe manifestations of Behçet's syndrome (BS). However, emergence of new manifestations has also been occasionally reported during IFX treatment. We aimed to assess the frequency of new manifestations in our BS patients treated with IFX.

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis.

Objectives: To analyze and compare sociodemographic features between Behçet uveitis and other non-infectious uveitis.

Materials And Methods: The data of adults with non-infectious uveitis in the nationwide uveitis database were analyzed and the sociodemographic features of patients with and without Behçet disease were compared.

Results: This study included data of 4,978 eyes of 3,363 patients from 33 centers.